Crossmark

Correction to: efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks

Published Online: 2023-10-06

Authors

Olalla, Julián

Pérez-Stachowski, Javier

Tortajada, Begoña

Arco, Alfonso Del

Márquez, Efrén

De la Torre, Javier

Nieto, Miriam

de Lomas, José María García

Prada, José Luis

García-Alegría, Javier
License Information

Text and Data Mining valid from 2023-10-06

Version of Record valid from 2023-10-06
More Information

Article History

First Online: 6 October 2023

Document is current